August 4th 2020EP. 1: Overview of Chronic Kidney Disease
August 4th 2020EP. 2: Role of Anemia in CKD
August 4th 2020EP. 3: Payer Perspective of Anemia in CKD
August 4th 2020EP. 4: Treatment of Anemia in CKD
August 4th 2020EP. 5: Standard of Care: Therapeutic Options for Anemia in CKD
August 4th 2020EP. 6: Anemia in CKD: CHOIR and TREAT Trials
August 4th 2020EP. 7: Economic Burden of Anemia in CKD
August 4th 2020EP. 8: Treatment of Anemia in CKD During COVID-19
August 4th 2020EP. 9: HIF Stabilizers for Anemia in CKD: Phase 3 Trials
August 4th 2020EP. 10: HIMALAYAS Trial: Long-Term Cardiovascular Safety Data
August 4th 2020EP. 11: HIF Stabilizers: Management of Anemia in CKD
August 4th 2020EP. 12: Payer Perspective of HIF Stabilizers for Anemia in CKD
August 4th 2020EP. 13: Anemia in CKD: HIF Stabilizers in Clinical Trials
August 4th 2020EP. 14: Future Treatment of Anemia in CKD: Impact of HIF Stabilizers
August 4th 2020EP. 15: Future Management of Anemia in CKD
